The Kanabo Group Begins a Three-Month Trial for its VapePod Device
Kanabo has applied for approval to conduct a clinical trial using its proprietary cannabis inhalation formula with its VapePod device to determine its bioavailability and efficacy. In accordance with ISO13485, Kanabo’s VapePod was produced in a certified GMP medical facility in full accordance with a formula that was developed and tested in Israel. This standard is often seen as the first […]
